Farmaforum Partnering Day 2026

23 Sept 2026 | Madrid, Spain

Register
Register
Register

ProductUpdated on 18 June 2026

Cannabis medicated chewing gums for addiction treatment

CEO at MEDICAL FLOWERS DEVELOPMENTS

MADRID, Spain

About

MFD is developing a new generation of cannabis medicated chewing gums designed to support behavioural therapies in addiction treatment.

The product is conceived as a pharmaceutical-grade, single-dose oral dosage form with controlled delivery through the buccal mucosa. The objective is to provide a complementary pharmacological tool to help manage anxiety peaks and craving during addiction treatment processes.

The first clinical program focuses on Cannabis Use Disorder (CUD), an unmet medical need with no approved pharmacological treatment today. Following this first validation, MFD aims to explore the potential of its technology in other addiction-related indications, including alcohol, cocaine and opioid dependence.

Looking for

  • Distribution Partner

Applies to

  • Pharmaceutical industry
  • Health innovation

Organisation

Similar opportunities